Amy Flattery

3.9k total citations
37 papers, 2.5k citations indexed

About

Amy Flattery is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Amy Flattery has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 10 papers in Pharmacology and 10 papers in Epidemiology. Recurrent topics in Amy Flattery's work include Antifungal resistance and susceptibility (16 papers), Fungal Biology and Applications (7 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Amy Flattery is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Fungal Biology and Applications (7 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Amy Flattery collaborates with scholars based in United States, Spain and Netherlands. Amy Flattery's co-authors include George K. Abruzzo, Christopher Gill, Ken Bartizal, Cameron Douglas, Jeffrey G. Smith, V.B. Pikounis, Martha Kurtz, L. Kong, Charles Gill and James F. Dropinski and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Amy Flattery

37 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Flattery United States 22 1.8k 1.2k 518 495 467 37 2.5k
Ken Bartizal United States 27 1.9k 1.1× 1.3k 1.0× 425 0.8× 535 1.1× 418 0.9× 49 2.6k
George K. Abruzzo United States 26 2.0k 1.1× 1.4k 1.1× 702 1.4× 724 1.5× 574 1.2× 59 3.1k
Martha Kurtz United States 24 1.8k 1.0× 1.1k 0.9× 1.0k 1.9× 514 1.0× 724 1.6× 35 2.7k
Beth A. Arthington‐Skaggs United States 24 2.3k 1.3× 1.7k 1.4× 536 1.0× 313 0.6× 270 0.6× 32 3.1k
Patrick Marichal Belgium 27 1.5k 0.8× 1.1k 0.9× 699 1.3× 404 0.8× 398 0.9× 38 2.6k
Erja Chryssanthou Sweden 30 1.7k 1.0× 1.6k 1.3× 316 0.6× 275 0.6× 276 0.6× 71 2.8k
Laura K. Najvar United States 38 2.9k 1.6× 2.4k 1.9× 429 0.8× 411 0.8× 442 0.9× 98 3.5k
Laura Alcázar‐Fuoli Spain 29 2.1k 1.2× 1.4k 1.1× 515 1.0× 495 1.0× 713 1.5× 52 2.9k
Josie E. Parker United Kingdom 32 1.7k 1.0× 1.2k 1.0× 663 1.3× 501 1.0× 852 1.8× 66 3.1k
Anthony Cacciapuoti United States 18 2.1k 1.2× 1.3k 1.1× 851 1.6× 272 0.5× 225 0.5× 39 2.7k

Countries citing papers authored by Amy Flattery

Since Specialization
Citations

This map shows the geographic impact of Amy Flattery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Flattery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Flattery more than expected).

Fields of papers citing papers by Amy Flattery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Flattery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Flattery. The network helps show where Amy Flattery may publish in the future.

Co-authorship network of co-authors of Amy Flattery

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Flattery. A scholar is included among the top collaborators of Amy Flattery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Flattery. Amy Flattery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hao, Paul A. Mann, Li Xiao, et al.. (2017). Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting. Cell chemical biology. 24(5). 576–588.e6. 72 indexed citations
2.
Warn, Peter, Pia Thömmes, Abdul Sattar, et al.. (2016). Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin. Antimicrobial Agents and Chemotherapy. 60(11). 6471–6482. 27 indexed citations
3.
Han, Seongah, Amy Flattery, David G. McLaren, et al.. (2011). Comparison of Lipoprotein Separation and Lipid Analysis Methodologies for Human and Cynomolgus Monkey Plasma Samples. Journal of Cardiovascular Translational Research. 5(1). 75–83. 11 indexed citations
4.
Chen, Zhu, Alison M. Strack, Ying Chen, et al.. (2011). Validation of Human ApoB and ApoAI Immunoturbidity Assays for Non-human Primate Dyslipidemia and Atherosclerosis Research. Journal of Cardiovascular Translational Research. 4(3). 373–383. 8 indexed citations
5.
Zhou, Xiaoyan, Martin F. Crook, Yonghua Zhu, et al.. (2011). Chronic Antagonism of the Mineralocorticoid Receptor Ameliorates Hypertension and End Organ Damage in a Rodent Model of Salt-Sensitive Hypertension. Clinical and Experimental Hypertension. 33(8). 538–547. 10 indexed citations
6.
Lassman, Michael E., Zhu Chen, Beth Murphy, et al.. (2011). A rapid method for cross‐species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra‐performance liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 26(2). 101–108. 44 indexed citations
7.
Gill, Charles, George K. Abruzzo, Amy Flattery, et al.. (2007). In Vivo Efficacy of a Novel Oxazolidinone Compound in Two Mouse Models of Infection. Antimicrobial Agents and Chemotherapy. 51(9). 3434–3436. 9 indexed citations
8.
Newport, George, Alan Kuo, Amy Flattery, et al.. (2003). Inactivation of Kex2p Diminishes the Virulence of Candida albicans. Journal of Biological Chemistry. 278(3). 1713–1720. 68 indexed citations
9.
Vicente, M. Francisca, Angeles Cabello, Gonzalo Platas, et al.. (2001). Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. Journal of Applied Microbiology. 91(5). 806–813. 32 indexed citations
10.
Bowman, Joel, George K. Abruzzo, Jennifer Anderson, et al.. (2001). Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate. Antimicrobial Agents and Chemotherapy. 45(12). 3474–3481. 183 indexed citations
11.
Cabello, Angeles, Gonzalo Platas, Javier Collado, et al.. (2001). Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms. International Microbiology. 4(2). 93–102. 32 indexed citations
12.
Peláez, Fernando, Angeles Cabello, Gonzalo Platas, et al.. (2000). The Discovery of Enfumafungin, a Novel Antifungal Compound Produced by an Endophytic Hormonema Species Biological Activity and Taxonomy of the Producing Organisms. Systematic and Applied Microbiology. 23(3). 333–343. 110 indexed citations
13.
Mandala, Suzanne, Rosemary Thornton, James A. Milligan, et al.. (1998). Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase. Journal of Biological Chemistry. 273(24). 14942–14949. 97 indexed citations
14.
Gill, Christopher, George K. Abruzzo, Amy Flattery, et al.. (1997). In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy. 41(11). 2326–2332. 262 indexed citations
15.
Smith, Jeffrey G., L. Kong, George K. Abruzzo, et al.. (1997). Evaluation of Experimental Therapeutics in a New Mouse Model ofHelicobacter felisUtilizing 16S rRNA Polymerase Chain Reaction for Detection. Scandinavian Journal of Gastroenterology. 32(4). 297–302. 6 indexed citations
16.
Douglas, Cameron, M. Meinz, Janet C. Onishi, et al.. (1997). Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrobial Agents and Chemotherapy. 41(11). 2471–2479. 262 indexed citations
17.
Kong, L., Jeffrey G. Smith, David Bramhill, et al.. (1996). A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model. Clinical and Diagnostic Laboratory Immunology. 3(1). 73–78. 13 indexed citations
18.
Gill, Charles, George K. Abruzzo, Amy Flattery, et al.. (1995). In vivo Evaluation of Three Acid-stable Azalide Compounds, L-701,677, L-708,299 and L-708,365 Compared to Erythromycin, Azithromycin and Clarithromycin.. The Journal of Antibiotics. 48(10). 1141–1147. 6 indexed citations
19.
Abruzzo, George K., Amy Flattery, Christopher Gill, et al.. (1995). Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and Chemotherapy. 39(5). 1077–1081. 67 indexed citations
20.
Flattery, Amy, et al.. (1991). Up-regulation of gene expression by FK 506.. PubMed. 23(6). 2870–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026